Official Sections CTRMS ISVCA IPITA IPTA ISODP IRTA IXA SPLIT TID

Joint TTS-SPLIT Webinar Series on Pediatric Liver Transplantation

TTS and SPLIT have teamed up to present webinars on pediatric liver transplantation.

TUESDAY, MAY 5, 2020
DISCUSSION ON SPLIT REGISTRY ANALYSIS DEMONSTRATING IMPROVED OUTCOMES...

TITLE: Discussion on SPLIT Registry Analysis Demonstrating Improved Outcomes for Liver Transplantation in Patients with Biliary Atresia Since PELD Implementation

Click here to view the recording (you must be logged into the website)

Discussant: Sarah A. Taylor, MD
Assistant Professor of Pediatrics (Gastroenterology, Hepatology and Nutrition)
Northwestern Feinberg School of Medicine
Chicago, IL, USA
Moderator: Manuel Rodriguez-Davalos, MD, FACS
Medical Director, Living Donor Liver Transplantation Program
Intermountain Medical Center
Surgical Director, Pediatric Liver Transplantation
Primary Children's Hospital - Intermountain Healthcare
Salt Lake City, UT, USA
TTS and SPLIT have teamed up to present webinars on pediatric liver transplantation. Since its inception in 1995, SPLIT steadily grew into an established collaborative, integrated infrastructure and community with synergistic platforms in research, education, patient advocacy, mentorship, quality improvement and clinical care. Over the years, SPLIT’s primary goal of improving outcomes for children who have undergone liver transplantation were powered via pharmaceutical (SPLIT 1.0), United States National Institutes of Health Grant (SPLIT 2.0), and self-funded (SPLIT 3.0) strategies. As the SPLIT Executive Council looked toward the future, it became clear that joining forces with a self-governing society with vast administrative and infrastructural support such as TTS would ensure the next chapter of SPLIT (4.0) to achieve and excel in SPLIT's targeted mission to improve the lives of children who require liver transplantation.

Objectives:

  1. Understand changes in disease severity of patients with biliary atresia awaiting liver transplantation
  2. Describe current risk factors affecting post-transplant patient and graft survival in biliary atresia and how these have evolved over time
  3. Understand the factors that influence risk stratification for deceased technical variant grafts in patients with biliary atresia 

Sarah A. Taylor's Biography:

Dr. Sarah Taylor is an Assistant Professor of Pediatric Gastroenterology, Hepatology and Nutrition at Northwestern’s Feinberg School of Medicine. She is a physician-scientist with an interest in pediatric liver disease and liver transplantation, and a research focus on the immune mechanism of neonatal liver disease. Her particular areas of research have included gestational alloimmune liver disease (GALD) and biliary atresia (BA). Through clinical research on outcomes in GALD and laboratory research on the mechanism of disease, her group has made a significant impact that has advanced the care of infants and mothers affected by GALD. Dr. Taylor's current translational research is directed at gaining a deeper understanding of the immune mechanism of BA, in particular the role of macrophages in disease progression after diagnosis with the ultimate goal to develop new treatment strategies. Clinically her area of focus is on pediatric liver disease and liver transplantation. She is passionate about improving care for our patients and seeks to use her research findings to improve patient outcomes.

Manuel Rodriguez-Davalos' Biography:

Manuel Rodriguez-Davalos, Medical Director, Living Donor Liver Transplantation Program, Intermountain Medical Center and Surgical Director, Pediatric Liver Transplantation, Primary Children's Hospital, Intermountain Healthcare. Dr. Rodriguez-Davalos has previously held positions in transplant at Yale University, Mount Sinai Medical Center and New York Medical College.

He is committed to innovation and collaboration to improve organ donation, transplantation and allocation systems to benefit those in need, especially children. He has particular interest in living donor transplants, organ allocation, and portal hypertension.

His current research involves living donor liver transplantation the use of partial grafts and extended criteria for donation in liver transplantation, and preservation techniques for decreasing ischemia-reperfusion injury.

He has served on numerous liver transplantation advisory boards and was a member at large of the United Network for Organ Sharing (UNOS ) Liver Committee and as well as the pediatric transplantation committee. He is part of the publications committee with IPTA, Education committee of TTS, Associate editor of our journal “Transplantation”, Task force for liver allocation with SPLiT and oversees the International Liver Transplant Society Pediatric Liver Transplant Registry.

He received his medical degree from the Anahuac University. He did a year of research in portal hypertension and hepatobiliary surgery at the National Institutes of Health System in Mexico. He was a surgical intern at the Mayo Clinic in Rochester, MN, and completed his surgical training at the Mayo Clinic Hospital in Scottsdale, AZ. He was a clinical fellow in multi-organ transplant surgery at Mount Sinai Medical Center.

Social

Contact

Staff Directory
+1-514-874-1717 x210
This email address is being protected from spambots. You need JavaScript enabled to view it.

Address

Society of Pediatric Liver Transplantation
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7
Canada